FDA approval also paves the way for WHO prequalification, which can accelerate national regulatory approvals.
- WHO Prequalification of Medicines Programme (PQP) helps ensure that medicines supplied by procurement agencies meet acceptable standards of quality, safety and efficacy.
About Lenacapavir
- Lenacapavir is an antiretroviral medicine that is used for HIV prevention as a Pre-Exposure Prophylaxis or PrEP.
- PrEP is a medication that can reduce the risk of HIV infection for individuals who are HIV-negative but are at risk of contracting the virus.
- WHO currently recommends oral PrEP, the dapivirine vaginal ring, and long-acting injectable cabotegravir (CAB-LA) as options for HIV PrEP.
About HIV
- Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system.
- Mechanism: HIV damages the immune system by infecting and destroying CD4 cells (CD4 T lymphocytes), a type of white blood cells.
- Transmission: HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids.
- It can also spread from a mother to her baby.
- Treatment: HIV can be prevented and treated with antiretroviral therapy (ART).
- Untreated HIV can progress to Acquired immunodeficiency syndrome (AIDS).
- According to HIV Estimations 2023 report, over 2.5 million people are living with HIV in India.
India’s Initiatives
|
